Polycythemia vera (PV) is classified as a myeloproliferative neoplasm characterized by the autonomous overproduction of erythrocytes by hematopoietic stem cells (HSC), occurring independently of erythropoietin (EPO) stimulation. This evidence concerns the gene EPO and myeloproliferative disorder.